Koninklijke DSM N.V. is a science-driven enterprise, headquartered in Heerlen, the Netherlands, and founded in 1902, that develops and delivers solutions for nutrition, health, and sustainable living globally. Its operations extend across the Netherlands, Switzerland, the rest of Europe, North and Latin America, China, other parts of Asia, and international markets. The company's activities are structured across its Nutrition, Materials, and Innovation Center segments. The Nutrition segment provides a comprehensive range of products for both animal and human well-being. For animal nutrition and health, it offers essential items such as vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics. Within human nutrition and health, its portfolio includes vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, prebiotics, and active pharmaceutical ingredients. This segment also encompasses market-ready and personalized nutrition solutions, human milk oligosaccharides, ingredients for skin, sun, hair care, and aromas, omega-3 fatty acids, along with specialized food enzymes, cultures, bio-preservation technologies, texturizing hydrocolloids, and savory taste and sugar reduction solutions. The Materials segment specializes in high-performance plastics crucial for manufacturing components in diverse industries like electrical and electronics, automotive, flexible food-packaging, and consumer goods. It also produces Dyneema, a unique fiber solution integral to personal protection, workwear, sports apparel, outdoor equipment, and various industrial applications including ropes, slings, synthetic chains, and nets for aquaculture and renewable energy sectors. Finally, the Innovation Center segment focuses on advancing biomedical materials and medical device manufacturing technologies. Its applications span critical areas such as cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. Additionally, this segment is responsible for commercializing yeast technology used in ethanol production.